Pricing Log in Create free account

Abpro Holdings Inc. (ABPO) vs Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX)

Abpro Holdings Inc. and Biodexa Pharmaceuticals PLC Unsponsored ADR are both Biotechnology companies. Abpro Holdings Inc. is the larger, with a market value of $1.4M against $1.3M — 1.1× the size. Biodexa Pharmaceuticals PLC Unsponsored ADR has negative trailing earnings, so its P/E is not meaningful; Abpro Holdings Inc. trades at 0.5×. Abpro Holdings Inc. has the higher net margin (0.00% vs −1,155.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, Abpro Holdings Inc. leads on 6 and Biodexa Pharmaceuticals PLC Unsponsored ADR on 3.

Valuation

Metric ABPO BDRX Biotechnology median
P/E 0.55 n/m 10.60
P/S n/m n/m 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.16 0.20 0.66
EV/Sales n/m (2.81) 9.02
Earnings yield 183.50% (102.95%) (32.88%)
Free cash flow yield (193.29%) 0.00% (23.13%)

Profitability

Metric ABPO BDRX Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (1,155.70%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (20.18%) 0.00% (51.96%)
Return on assets 46.10% 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABPO BDRX Biotechnology median
Revenue growth (TTM) — 60.22% 6.76%
EPS growth (last fiscal year) 94.15% 89.62% 29.88%
Revenue growth, 5-year CAGR — (28.78%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABPO BDRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.62 2.41 4.97
Net debt to EBITDA 0.01 1.00 1.01

Dividend

Metric ABPO BDRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABPO BDRX Biotechnology median
Market cap 1.42m 1.25m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack